Early Prediction of Gestational Diabetes in High-risk Women Based on Breath Metabolomics
A Cohort Study in Women at High Risk for Gestational Diabetes Based on Breath Metabolomics
1 other identifier
observational
600
1 country
1
Brief Summary
This study aim to develope novel breath markers of gestational diabetes through a prospective high-risk population cohort study and achieve early prediction of gestational diabetes based on an interpretable machine learning model.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Dec 2024
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
December 23, 2024
CompletedStudy Start
First participant enrolled
December 25, 2024
CompletedFirst Posted
Study publicly available on registry
December 31, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 1, 2026
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2027
ExpectedMay 31, 2025
December 1, 2024
1.2 years
December 23, 2024
May 27, 2025
Conditions
Outcome Measures
Primary Outcomes (1)
Incidence of gestational diabetes mellitus
24-28 weeks gestation
Study Arms (2)
Gestational Diabetes Group
control group
Eligibility Criteria
The population in this study include pregnant women aged 18-55 years and at 11-14 weeks gestation with at least one risk factor for GDM
You may not qualify if:
- Diabetes mellitus or abnormal glucose metabolism before pregnancy
- Hyperemesis gravidarum (urine ketone positive))
- Thyroid dysfunction
- Asthmatic patients
- Hypertensive diseases that are difficult to control
- Severe hepatic and renal insufficiency or severe electrolyte disturbance
- Malignant tumor
- Acute inflammation
- lung disease
- Patients with gastritis, duodenum and other digestive system diseases
- Those with upper respiratory or oral problems who cannot cooperate with expiratory collection
- smoker
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Tianjin Central Hospital of Gynecology Obstetrics
Tianjin, China
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
December 23, 2024
First Posted
December 31, 2024
Study Start
December 25, 2024
Primary Completion
March 1, 2026
Study Completion (Estimated)
December 1, 2027
Last Updated
May 31, 2025
Record last verified: 2024-12